Topical targretin and intralesional interferon alfa for cutaneous lymphoma of the scalp.
Trent
Jennifer T
JT
University of Miami School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, FL 33136, USA.
Romanelli
Paolo
P
Kerdel
Francisco A
FA
D000287:Administration, Topical; D000077610:Bexarotene; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D015552:Injections, Intralesional; D016898:Interferon-alpha / Q000008:administration & dosage*; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy* / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012536:Scalp Dermatoses / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D012720:Severity of Illness Index; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage*; D016896:Treatment Outcome
D016898:Interferon-alpha; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene